Literature DB >> 21608081

Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.

Michela Deleidi1, Gunnar Hargus, Penelope Hallett, Teresia Osborn, Ole Isacson.   

Abstract

Immune rejection and risk of tumor formation are perhaps the greatest hurdles in the field of stem cell transplantation. Here, we report the generation of several lines of induced pluripotent stem cells (iPSCs) from cynomolgus macaque (CM) skin fibroblasts carrying specific major histocompatibility complex (MHC) haplotypes. To develop a collection of MHC-matched iPSCs, we genotyped the MHC locus of 25 CMs by microsatellite polymerase chain reaction analysis. Using retroviral infection of dermal skin fibroblasts, we generated several CM-iPSC lines carrying different haplotypes. We characterized the immunological properties of CM-iPSCs and demonstrated that CM-iPSCs can be induced to differentiate in vitro along specific neuronal populations, such as midbrain dopaminergic (DA) neurons. Midbrain-like DA neurons generated from CM-iPSCs integrated into the striatum of a rodent model of Parkinson's disease and promoted behavioral recovery. Importantly, neither tumor formation nor inflammatory reactions were observed in the transplanted animals up to 6 months after transplantation. We believe that the generation and characterization of such histocompatible iPSCs will allow the preclinical validation of safety and efficacy of iPSCs for neurodegenerative diseases and several other human conditions in the field of regenerative medicine.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Year:  2011        PMID: 21608081      PMCID: PMC3340906          DOI: 10.1002/stem.662

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  45 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

3.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

Review 4.  Immunological barriers to embryonic stem cell-derived therapies.

Authors:  Tomo Sarić; Lukas P Frenzel; Jürgen Hescheler
Journal:  Cells Tissues Organs       Date:  2008-02-27       Impact factor: 2.481

5.  HLA-haplotype banking and iPS cells.

Authors:  Norio Nakatsuji; Fumiaki Nakajima; Katsushi Tokunaga
Journal:  Nat Biotechnol       Date:  2008-07       Impact factor: 54.908

6.  A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system.

Authors:  P Pakzaban; T W Deacon; L H Burns; J Dinsmore; O Isacson
Journal:  Neuroscience       Date:  1995-04       Impact factor: 3.590

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected?

Authors:  H Widner; P Brundin
Journal:  Cell Transplant       Date:  1993 Jul-Aug       Impact factor: 4.064

9.  The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.

Authors:  Arnar Astradsson; Bruce G Jenkins; Ji-Kyung Choi; Penelope J Hallett; Michele A Levesque; Jack S McDowell; Anna-Liisa Brownell; Roger D Spealman; Ole Isacson
Journal:  Neurobiol Dis       Date:  2009-06-06       Impact factor: 5.996

10.  Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons.

Authors:  N S Haque; C J LeBlanc; O Isacson
Journal:  Cell Transplant       Date:  1997 May-Jun       Impact factor: 4.139

View more
  26 in total

Review 1.  Haplessly hoping: macaque major histocompatibility complex made easy.

Authors:  Roger W Wiseman; Julie A Karl; Patrick S Bohn; Francesca A Nimityongskul; Gabriel J Starrett; David H O'Connor
Journal:  ILAR J       Date:  2013

Review 2.  Neurotransplantation: lux et veritas, fiction or reality?

Authors:  C Pendleton; I Ahmed; A Quinones-Hinojosa
Journal:  J Neurosurg Sci       Date:  2011-12       Impact factor: 2.279

3.  Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

Authors:  Penelope J Hallett; Michela Deleidi; Arnar Astradsson; Gaynor A Smith; Oliver Cooper; Teresia M Osborn; Maria Sundberg; Michele A Moore; Eduardo Perez-Torres; Anna-Liisa Brownell; James M Schumacher; Roger D Spealman; Ole Isacson
Journal:  Cell Stem Cell       Date:  2015-02-26       Impact factor: 24.633

4.  Induced pluripotent stem cells in rat models of Parkinson's disease: A systematic review and meta-analysis.

Authors:  Yunxia Zhang; Meiling Ge; Qiukui Hao; Birong Dong
Journal:  Biomed Rep       Date:  2018-01-30

Review 5.  Converted neural cells: induced to a cure?

Authors:  Weiqi Zhang; Shunlei Duan; Ying Li; Xiuling Xu; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2012-03-11       Impact factor: 14.870

Review 6.  Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration.

Authors:  Joshua C Orack; Michela Deleidi; David Pitt; Kedar Mahajan; Jacqueline A Nicholas; Aaron L Boster; Michael K Racke; Manuel Comabella; Fumihiro Watanabe; Jaime Imitola
Journal:  Stem Cells Transl Med       Date:  2015-01-15       Impact factor: 6.940

Review 7.  Assisted reproductive technologies in the common marmoset: an integral species for developing nonhuman primate models of human diseases.

Authors:  Jenna Kropp; Andrea Di Marzo; Thaddeus Golos
Journal:  Biol Reprod       Date:  2017-02-01       Impact factor: 4.285

8.  Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Authors:  Marina E Emborg; Yan Liu; Jiajie Xi; Xiaoqing Zhang; Yingnan Yin; Jianfeng Lu; Valerie Joers; Christine Swanson; James E Holden; Su-Chun Zhang
Journal:  Cell Rep       Date:  2013-03-14       Impact factor: 9.423

Review 9.  Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.

Authors:  Xiaoyun Xu; Jinsha Huang; Jie Li; Ling Liu; Chao Han; Yan Shen; Guoxin Zhang; Haiyang Jiang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Cell Prolif       Date:  2016-01-08       Impact factor: 6.831

10.  Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Authors:  Maria Sundberg; Helle Bogetofte; Tristan Lawson; Johan Jansson; Gaynor Smith; Arnar Astradsson; Michele Moore; Teresia Osborn; Oliver Cooper; Roger Spealman; Penelope Hallett; Ole Isacson
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.